trimethylamine has been researched along with Coronary Disease in 2 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, P | 1 |
| Zhao, XN | 1 |
| Ma, YY | 1 |
| Tang, TJ | 1 |
| Wang, SS | 1 |
| Wang, L | 1 |
| Huang, JL | 1 |
| von Eckardstein, A | 1 |
1 review available for trimethylamine and Coronary Disease
| Article | Year |
|---|---|
Virtual screening analysis of natural flavonoids as trimethylamine (TMA)-lyase inhibitors for coronary heart disease.
Topics: Coronary Disease; Flavonoids; Hesperidin; Humans; Lyases; Molecular Docking Simulation | 2022 |
1 other study available for trimethylamine and Coronary Disease
| Article | Year |
|---|---|
Trimethyllysine and trimethylamine-N-oxide - pathogenic factors or surrogate markers of increased cardiovascular disease risk?
Topics: Biomarkers; Cardiovascular Diseases; Coronary Disease; Humans; Lysine; Methylamines; Myocardial Infa | 2020 |